ZA865826B - Peptide derivatives having a lactone or cycloamide structure,process for the preparation thereof and pharmaceutical compositions containing them - Google Patents

Peptide derivatives having a lactone or cycloamide structure,process for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
ZA865826B
ZA865826B ZA865826A ZA865826A ZA865826B ZA 865826 B ZA865826 B ZA 865826B ZA 865826 A ZA865826 A ZA 865826A ZA 865826 A ZA865826 A ZA 865826A ZA 865826 B ZA865826 B ZA 865826B
Authority
ZA
South Africa
Prior art keywords
cycloamide
lactone
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
ZA865826A
Other languages
English (en)
Inventor
Michel Vincent
Georges Remond
Jean Lepagnol
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA865826B publication Critical patent/ZA865826B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA865826A 1985-08-05 1986-08-04 Peptide derivatives having a lactone or cycloamide structure,process for the preparation thereof and pharmaceutical compositions containing them ZA865826B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8511936A FR2585709B1 (fr) 1985-08-05 1985-08-05 Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA865826B true ZA865826B (en) 1987-04-29

Family

ID=9321967

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA865826A ZA865826B (en) 1985-08-05 1986-08-04 Peptide derivatives having a lactone or cycloamide structure,process for the preparation thereof and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US4725581A (da)
EP (1) EP0217688B1 (da)
JP (2) JPS6233198A (da)
AT (1) ATE56976T1 (da)
AU (1) AU581599B2 (da)
CA (1) CA1276397C (da)
DE (1) DE3674525D1 (da)
DK (1) DK364786A (da)
ES (1) ES2000128A6 (da)
FR (1) FR2585709B1 (da)
GR (1) GR862059B (da)
IE (1) IE58541B1 (da)
NZ (1) NZ217079A (da)
PT (1) PT83145B (da)
ZA (1) ZA865826B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 4−アミノピリジン誘導体及びその酸付加塩
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
FR2649110B1 (fr) * 1989-06-29 1994-10-21 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2663336B1 (fr) * 1990-06-18 1992-09-04 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IT1242002B (it) * 1990-10-03 1994-02-02 Polifarma Spa Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido quello centrale
US5504071A (en) * 1990-10-03 1996-04-02 Polifarma S.P.A. Compounds with a sequence of three radicals, the central one being α-a
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
JP2000505425A (ja) * 1996-02-05 2000-05-09 イーライ・リリー・アンド・カンパニー Trhを用いるベータ―アミロイドペプチドに関連する状態の処置方法
DE19616509A1 (de) * 1996-04-25 1998-01-15 Asta Medica Ag Neue spezifische Immunophilin-Liganden als Antiasthmatika, Immunsuppressiva
AU2003248584A1 (en) * 2002-03-01 2003-09-16 Warner-Lambert Company Llc Method of treating osteoarthritis
US7628342B2 (en) 2004-05-11 2009-12-08 Daiwa Can Company Liquefied gas dispensing nozzle and liquefied gas dispensing apparatus
EP1993527A4 (en) 2006-01-26 2009-08-05 Univ Rochester INHIBITION OF AMYLOID BETA PEPTIDE / RAGE INTERACTION AT BLOOD BRAIN BARRIER

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド
US4260601A (en) * 1979-10-23 1981-04-07 Nyegaard & Co. A/S Chemical compounds
US4293481A (en) * 1980-07-24 1981-10-06 E. R. Squibb & Sons, Inc. Tripeptide inhibitors of angiotensin-converting enzyme
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel

Also Published As

Publication number Publication date
AU6081286A (en) 1987-02-12
DK364786D0 (da) 1986-07-31
GR862059B (en) 1986-12-24
DK364786A (da) 1987-02-06
PT83145B (pt) 1989-03-30
IE58541B1 (en) 1993-10-06
IE862085L (en) 1987-02-05
JPH0259160B2 (da) 1990-12-11
EP0217688B1 (fr) 1990-09-26
ES2000128A6 (es) 1987-12-16
US4725581A (en) 1988-02-16
FR2585709A1 (fr) 1987-02-06
FR2585709B1 (fr) 1987-10-02
JPH0229680B2 (da) 1990-07-02
ATE56976T1 (de) 1990-10-15
NZ217079A (en) 1988-05-30
CA1276397C (fr) 1990-11-13
JPH01230597A (ja) 1989-09-14
EP0217688A1 (fr) 1987-04-08
PT83145A (fr) 1986-09-01
AU581599B2 (en) 1989-02-23
JPS6233198A (ja) 1987-02-13
DE3674525D1 (de) 1990-10-31

Similar Documents

Publication Publication Date Title
AU581599B2 (en) New peptide compounds having a lactone or cycloamide structure
GB8718708D0 (en) Apparatus for treatment of spinal disorders
GB8716925D0 (en) Apparatus for treatment of spinal disorders
HUT54891A (en) Process for producing pharmaceutical compositions against lesions destroying nerve tissue
IT1147087B (it) Nuovi preparati farmaceutici per il trattamento dei disordini del sistema nervoso centrale e procedimento per la loro preparazione
PT84899A (en) Process for the preparation of pharmaceutical compositions containing ?-phenyl-1,2-benzisoselenazol-3(2h)-one for the treatment of skin diseases
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
EP0324802A4 (en) Method for the treatment of body tissues and the administration of drugs thereto
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
GB8808598D0 (en) Pharmaceutical compositions for treatment of prophylaxis of skin disorders
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
IL78307A0 (en) Psoralene-based bath composition for treatment of skin disorders
AU574216B2 (en) Spirobenzodiazepine derivatives
YU22186A (en) Process for obtaining compound for healing skin disease psoriazis
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
FR2575158B1 (fr) Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
ZA881828B (en) Preparation for treatment of skin disorders
PL252062A1 (en) Method of obtaining pharmaceutical preparations exibiting prolonged therapeutic action
HU895238D0 (en) Process for the preparation of pharmaceutical composition suitable for the treatment of pyogenous skin diseases
Kuzminskaya et al. Cholinesterase activity and ATP in development of long-term neurotoxicity caused by tri-o-cresyl phosphate.
HU895239D0 (en) Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases
AU8066187A (en) Method and therapeutic compositions for the treatment of bleeding disorders
IL93030A0 (en) Composition containing thymo-pentin for topical treatment of skin disorders
IE842027L (en) Treatment of skin disorders